Follow
Athanasios Papatheodorou
Athanasios Papatheodorou
Molecular Biologist
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
Helicobacter pylori infection in patients with nonalcoholic fatty liver disease
SA Polyzos, J Kountouras, A Papatheodorou, K Patsiaoura, E Katsiki, ...
Metabolism 62 (1), 121-126, 2013
1832013
Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women—the six-month effect of risedronate and teriparatide
SA Polyzos, AD Anastasilakis, C Bratengeier, W Woloszczuk, ...
Osteoporosis international 23, 1171-1176, 2012
1602012
Genotype–phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B)
E Panagiotakaki, M Tzetis, N Manolaki, G Loudianos, A Papatheodorou, ...
American Journal of Medical Genetics Part A 131 (2), 168-173, 2004
1222004
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post …
E Terpos, E Kastritis, D Christoulas, M Gkotzamanidou, ...
Annals of Oncology 23 (10), 2681-2686, 2012
1182012
Smoking is a significant determinant of low serum vitamin D in young and middle-aged healthy males
EN Kassi, S Stavropoulos, P Kokkoris, A Galanos, P Moutsatsou, C Dimas, ...
Hormones 14, 241-250, 2015
1172015
Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis
E Terpos, K Fragiadaki, M Konsta, C Bratengeier, A Papatheodorou, ...
Clinical and Experimental Rheumatology-Incl Supplements 29 (6), 921, 2011
1062011
The effect of teriparatide on serum dickkopf‐1 levels in postmenopausal women with established osteoporosis
AD Anastasilakis, SA Polyzos, A Avramidis, KA Toulis, A Papatheodorou, ...
Clinical endocrinology 72 (6), 752-757, 2010
752010
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration
E Voskaridou, D Christoulas, C Xirakia, K Varvagiannis, G Boutsikas, ...
haematologica 94 (5), 725, 2009
742009
Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis
P Makras, SA Polyzos, A Papatheodorou, P Kokkoris, D Chatzifotiadis, ...
Clinical endocrinology 79 (4), 499-503, 2013
672013
Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent …
M Tzetis, M Kaliakatsos, M Fotoulaki, A Papatheodorou, S Doudounakis, ...
Clinical genetics 71 (5), 451-457, 2007
592007
Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
AD Anastasilakis, SA Polyzos, A Gkiomisi, ZG Saridakis, D Digkas, ...
Osteoporosis International 26, 2521-2527, 2015
572015
Circulating angiopoietin‐1 to angiopoietin‐2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with …
E Terpos, K Anargyrou, E Katodritou, E Kastritis, A Papatheodorou, ...
International Journal of Cancer 130 (3), 735-742, 2012
472012
The combination of lenalidomide and dexamethasone reduces bone resorption in responding patients with relapsed/refractory multiple myeloma but has no effect on bone formation …
E Terpos, D Christoulas, E Kastritis, E Katodritou, A Papatheodorou, ...
American journal of Hematology 89 (1), 34-40, 2014
462014
Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers
AD Anastasilakis, SA Polyzos, ZA Efstathiadou, M Savvidis, ...
Metabolism 64 (10), 1291-1297, 2015
422015
Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index
SA Polyzos, J Kountouras, A Papatheodorou, E Katsiki, K Patsiaoura, ...
Annals of hepatology 12 (5), 749-757, 2013
392013
Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment
AD Anastasilakis, SA Polyzos, P Makras, M Savvides, GT Sakellariou, ...
Hormone and Metabolic Research 46 (02), 145-149, 2014
362014
Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-α gene—Their association with obstructive pulmonary disease in Greek patients
A Papatheodorou, P Latsi, C Vrettou, A Dimakou, A Chroneou, ...
Clinical biochemistry 40 (12), 843-850, 2007
322007
Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget’s disease
SA Polyzos, AD Anastasilakis, I Litsas, Z Efstathiadou, M Kita, G Arsos, ...
Journal of bone and mineral metabolism 28, 706-712, 2010
302010
Development of novel microarray methodology for the study of mutations in the SERPINA1 and ADRB2 genes—Their association with Obstructive Pulmonary Disease and Disseminated …
A Papatheodorou, P Makrythanasis, M Kaliakatsos, A Dimakou, ...
Clinical biochemistry 43 (1-2), 43-50, 2010
282010
Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide
AD Anastasilakis, SA Polyzos, A Avramidis, A Papatheodorou, E Terpos
Hormone and metabolic research, 559-562, 2009
272009
The system can't perform the operation now. Try again later.
Articles 1–20